Publication

Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Dopaminergic neurodegeneration induced by Parkinson's disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity

Chat with Graph Search

Associations of genetic and infectious risk factors with coronary heart disease

Structure and regulation of the myotonic dystrophy kinase-related Cdc42-binding kinase

Deconstructing and Reconstructing the Complexity of Tau pathology

Online interoperable resources for building hippocampal neuron models via the Hippocampus Hub

N-terminal mutant huntingtin deposition correlates with CAG repeat length and symptom onset, but not neuronal loss in Huntington's disease

Towards elucidating the structural and cellular determinants of a-synuclein seeding and toxicity

Pathological substrate of memory impairment in multiple system atrophy

Astrocyte-targeting RNA interference against mutated superoxide dismutase 1 induces motoneuron plasticity and protects fast-fatigable motor units in a mouse model of amyotrophic lateral sclerosis

Alpha-synuclein as a Potential Biomarker for Parkinson’s Disease and Other Synucleinopathies: Gaps, Challenges, and Opportunities

Simulating the progression of brain structural alterations in Parkinson's disease

Capturing the heterogeneity of alpha-synuclein pathology in synucleinopathies

Advanced metabolite mapping at ultra-high field using 1H-MRS, 1H-MRSI and macromolecules: applications in a rat model of type C hepatic encephalopathy

Opportunities and challenges of alpha-synuclein as a potential biomarker for Parkinson's disease and other synucleinopathies

Fading of brain network fingerprint in Parkinson's disease predicts motor clinical impairment